Onkologie (Olomouc, Print).
2018 ;
12 (5) :
217-223.
x
x
- Keywords
- radium-223, enzalutamid, cabazitaxel, ARTA,
- MeSH
- Abiraterone Acetate therapeutic use MeSH
- Androgen Antagonists classification therapeutic use MeSH
- Drug Resistance, Neoplasm MeSH
- Molecular Targeted Therapy MeSH
- Docetaxel therapeutic use MeSH
- Phenylthiohydantoin analogs & derivatives MeSH
- Humans MeSH
- Neoplasm Metastasis MeSH
- Survival Rate MeSH
- Prostatic Neoplasms, Castration-Resistant * drug therapy pathology radiotherapy MeSH
- Antineoplastic Agents, Immunological therapeutic use MeSH
- Antineoplastic Agents classification adverse effects therapeutic use MeSH
- Radium classification therapeutic use MeSH
- Taxoids classification therapeutic use MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Male MeSH
Onkologie (Olomouc, Print).
2018 ;
12 (5) :
224-230.
x
x
- Keywords
- enzalutamid, ARTA, radium-223,
- MeSH
- Abiraterone Acetate adverse effects therapeutic use MeSH
- Androgen Antagonists classification adverse effects therapeutic use MeSH
- Phenylthiohydantoin analogs & derivatives MeSH
- Antineoplastic Agents, Hormonal adverse effects therapeutic use MeSH
- Drug Therapy, Combination MeSH
- Humans MeSH
- Neoplasm Metastasis MeSH
- Survival Rate MeSH
- Prostatic Neoplasms, Castration-Resistant drug therapy therapy MeSH
- Prostatic Neoplasms * drug therapy radiotherapy therapy MeSH
- Neoplasms, Hormone-Dependent therapy MeSH
- Prednisone therapeutic use MeSH
- Antineoplastic Agents classification adverse effects therapeutic use MeSH
- Radium classification therapeutic use MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Taxoids classification adverse effects therapeutic use MeSH
- Age Factors * MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
